Hypermarcas (OTCMKTS:HYPMY – Get Free Report) passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $4.09 and traded as high as $4.23. Hypermarcas shares last traded at $4.18, with a volume of 2,459 shares trading hands.
Analyst Upgrades and Downgrades
Several research firms recently issued reports on HYPMY. Jefferies Financial Group raised Hypermarcas to a “strong-buy” rating in a research note on Monday, July 20th. Zacks Research upgraded shares of Hypermarcas to a “hold” rating in a research note on Wednesday, April 29th. One analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy”.
View Our Latest Stock Report on Hypermarcas
Hypermarcas Price Performance
Hypermarcas (OTCMKTS:HYPMY – Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.14 earnings per share for the quarter, topping analysts’ consensus estimates of $0.13 by $0.01. Hypermarcas had a net margin of 19.77% and a return on equity of 14.63%. As a group, equities analysts anticipate that Hypermarcas will post 0.53 EPS for the current fiscal year.
Hypermarcas Company Profile
Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.
Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.
Read More
- Five stocks we like better than Hypermarcas
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for Hypermarcas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypermarcas and related companies with MarketBeat.com's FREE daily email newsletter.
